|
Synonyms: Compound 1 [US20260042752] | TRI611
Compound class:
Synthetic organic
Comment: TRI-611 (TRIANA Biomedicines) is a CNS-penetrant, CRBN-mediated molecular glue degrader of ALK receptor tyrosine kinase (ALK) [1-2]. As the ligand engages an allosteric site it is able to drive ubiquitination and degradation of abnormal ALK proteins, including clinically relevant variants that confer resistance to existing tyrosine kinase inhibitors, and in tumours with ALK oncogenic fusions.
|
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Conery AR, La DS, Alekseyenko AA, Marcoux D, Bart AG, Harlow ML, Arsenault PR, Cantone NR, Casaubon RL, Constan A et al.. (2026)
TRI-611, a selective, brain-penetrant molecular glue degrader of ALK. Nature, 658 (8134): 241-249. [PMID:42717093] |
|
2. La D. (2026)
Anaplastic lymphoma kinase (alk) degraders and uses thereof. Patent number: US20260042752A1. Assignee: Triana Biomedicines Inc. Priority date: 14/10/2025. Publication date: 12/02/2026. |